ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998